I expect a positive surprise with an increase in sales on the Q4 financials coming out imo. With all that's going on with CVS expansion, Entry into the VA formulary, Mundipharma, and Boots ( although I don't expect to see results until Q1 '19 ). Let's not forget BIEL has an agreement with one of the country's largest hospice providers providing Actipatch's under ' The Right To Try Law ' serving the needs of some of the 1.2 million hospice patients in the U.S. with which Keith anticipates a significant increase in sales on this alone. As Keith stated in his last interview " the pump is primed " !
$Go Biel$